참고문헌
- Beatty WW, Butters N, Janowsky D. 1986. Memory failure after scopolamine treatment: implications for cholinergic hypothesis of dementia. Behav Neural Biol 45: 196-211 https://doi.org/10.1016/S0163-1047(86)90772-7
- Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA. 1992. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108: 485-494 https://doi.org/10.1007/BF02247426
- Eidi M, Zarrindast MR, Eidi A, Oryan S, Parivar K. 2003. Effects of histamine and cholinergic systems on memory retention of passive avoidance learning in rats. Eur J Pharmacol 465: 91-96 https://doi.org/10.1016/S0014-2999(03)01440-7
- Dunnett SB, Toniolo G, Fine A, Ryan CN, Bjorklund A, Iversen SD. 1985. Transplantation of embryonic ventral forebrain neurons to the nucleus basalis magnocellularis: II. Sensorimotor and learning impairments. Neuroscience 16: 787-797 https://doi.org/10.1016/0306-4522(85)90094-6
- Levy ML, Cummings JL, Kahn-Rose R. 1999. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease. Gerontol 45: 15-22 https://doi.org/10.1159/000052760
- Musial A, Bajda M, Malawska B. 2007. Recent develop ments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr Med Chem 14: 2654-2679 https://doi.org/10.2174/092986707782023217
- Zhong CB, Pan YP, Tong XY, Xu XH, Wang XL. 2005. Delayed rectifier potassium currents and Kv2.1 mRNA increase in hippocampal neurons of scopolamine-induced memory-deficient rats. Neurosci Lett 373: 99-104 https://doi.org/10.1016/j.neulet.2004.09.069
- Ebert U, Kirch W. 1998. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 28: 944-949 https://doi.org/10.1046/j.1365-2362.1998.00393.x
- Collerton D. 1986. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19: 1-28 https://doi.org/10.1016/0306-4522(86)90002-3
- Heber D, Lu QY. 2002. Overview of mechanisma of action of lycopene. Exp Bio Med 227: 920-923 https://doi.org/10.1177/153537020222701013
- Rao AV, Agarwal S. 2000. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 19: 563-569 https://doi.org/10.1080/07315724.2000.10718953
- Bhuvaneswari V, Nagini S. 2005. Lycopene: a review of its potential as an anticancer agent. Curr Med Chem Anticancer Agents 5: 627-635 https://doi.org/10.2174/156801105774574667
- Rao AV, Ray MR, Rao LG. 2006. Lycopene. Adv Food Nutr Res 51: 99-164 https://doi.org/10.1016/S1043-4526(06)51002-2
- George B, Kaur C, Khurdiya DS, Kapoor HC. 2004. Antioxidant in tomato (Lycopene esculentum) as a function of genotype. Food Chem 84: 45-51 https://doi.org/10.1016/S0308-8146(03)00165-1
- Morris RG. 1984. Development of water maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60 https://doi.org/10.1016/0165-0270(84)90007-4
- Ellman GL, Courtney KD, Andres VJ, Featherstone RM. 1961. A new and rapid colormetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95 https://doi.org/10.1016/0006-2952(61)90145-9
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1993. Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275
- Kim DH, Kim DY, Kim YC, Jung JW, Lee SJ, Yoon BH, Cheong JH, Kim YS, Kang SS, Ko KH, Ryu JH. 2007. Nodakain, a coumarin compound, ameliorates scopolamine-induced memory disruption in mice. Life Sci 80: 1944-1950 https://doi.org/10.1016/j.lfs.2007.02.023
- Fan Y, Hu JF, Li J, Yang Z, Xin XL, Wang J, Ding J, Geng MY. 2005. Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 374: 222-226 https://doi.org/10.1016/j.neulet.2004.10.063
- Levy AI. 1996. Muscarinic acetylcholine receptor expression in memory circus; implications for treatment of Alzheimer disease. Proc Natl Acad Sci 93: 13541-13546 https://doi.org/10.1073/pnas.93.24.13541
- Cutler NR, Stramelk JJ. 2001. Review of the next generation of Alzheimer's disease therapeutics; challenges for drug development. Prog Neuropsychopharmacol Biol Psychiatry 25: 27-57 https://doi.org/10.1016/S0278-5846(00)00147-0
- Ezio G. 1998. Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrines to future applications. Neurochem Int 32: 413-419 https://doi.org/10.1016/S0197-0186(97)00124-1
- Siddiqui MF, Levey AI. 1999. Cholinergic therapies in Alzheimer's disease. Drug Future 24: 417-444 https://doi.org/10.1358/dof.1999.024.04.668318
- Aust O, Sies H, Atahl W, Polidory MC. 2001. Analysis of lipophilic abtioxidants in human serum and tissues: tocopherols and carotenoids. J Chromatogr 936: 83-93 https://doi.org/10.1016/S0021-9673(01)01269-9
- Rao AV, Agarwal S. 1999. Role of lycopene as antioxidant carotenoid in the prevention of chronic disease: a review. Nutr Res 19: 305-323 https://doi.org/10.1016/S0271-5317(98)00193-6
- Clinton SK. 2000. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 56: 35-51 https://doi.org/10.1111/j.1753-4887.1998.tb01691.x
- Emilla AM M, Resina LM, F, Danilo WF, Daniela N, Fabiola S, France B, Emil K. 2005. Effects of diet energy level and tomato powder consumption on antioxidant status in rats. Clin Nutr 24: 1038-1046 https://doi.org/10.1016/j.clnu.2005.08.005
-
Lee SY, Son DH, Ha TY, Hong JT. 2005. Protective effect of sesaminol glucosides on memory impairment and
${\beta}$ ,${\gamma}$ -secretase activity in vivo. Yahhak Hoeji 49: 168-173
피인용 문헌
- The Aqueous Extract of Rubus coreanus Miquel Improves Scopolamine-Induced Memory Impairment in ICR Mice vol.41, pp.2, 2012, https://doi.org/10.3746/jkfn.2012.41.2.192